- Home
- VSTM vs TTOO Comparison
VSTM vs TTOO Comparison
Compare VSTM & TTOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- TTOO
- Stock Information
- Founded
- VSTM 2010
- TTOO 2006
- Country
- VSTM United States
- TTOO United States
- Employees
- VSTM N/A
- TTOO N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- TTOO Medical/Dental Instruments
- Sector
- VSTM Health Care
- TTOO Health Care
- Exchange
- VSTM Nasdaq
- TTOO Nasdaq
- Market Cap
- VSTM 132.0M
- TTOO 36.4M
- IPO Year
- VSTM 2012
- TTOO 2014
- Fundamental
- Price
- VSTM $3.88
- TTOO $0.97
- Analyst Decision
- VSTM Strong Buy
- TTOO Hold
- Analyst Count
- VSTM 8
- TTOO 1
- Target Price
- VSTM $14.57
- TTOO $5.00
- AVG Volume (30 Days)
- VSTM 1.1M
- TTOO 710.5K
- Earning Date
- VSTM 11-06-2024
- TTOO 11-13-2024
- Dividend Yield
- VSTM N/A
- TTOO N/A
- EPS Growth
- VSTM N/A
- TTOO N/A
- EPS
- VSTM N/A
- TTOO N/A
- Revenue
- VSTM $10,000,000.00
- TTOO $7,164,000.00
- Revenue This Year
- VSTM N/A
- TTOO $50.31
- Revenue Next Year
- VSTM $125.69
- TTOO $117.92
- P/E Ratio
- VSTM N/A
- TTOO N/A
- Revenue Growth
- VSTM N/A
- TTOO N/A
- 52 Week Low
- VSTM $2.10
- TTOO $0.90
- 52 Week High
- VSTM $14.22
- TTOO $8.38
- Technical
- Relative Strength Index (RSI)
- VSTM 63.77
- TTOO 18.34
- Support Level
- VSTM $3.11
- TTOO $0.90
- Resistance Level
- VSTM $3.76
- TTOO $1.86
- Average True Range (ATR)
- VSTM 0.33
- TTOO 0.15
- MACD
- VSTM 0.04
- TTOO -0.00
- Stochastic Oscillator
- VSTM 94.26
- TTOO 5.72
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.